545 related articles for article (PubMed ID: 29309917)
1. Breast cancer bone metastases: pathogenesis and therapeutic targets.
Brook N; Brook E; Dharmarajan A; Dass CR; Chan A
Int J Biochem Cell Biol; 2018 Mar; 96():63-78. PubMed ID: 29309917
[TBL] [Abstract][Full Text] [Related]
2. Bone Metastasis of Breast Cancer.
Tahara RK; Brewer TM; Theriault RL; Ueno NT
Adv Exp Med Biol; 2019; 1152():105-129. PubMed ID: 31456182
[TBL] [Abstract][Full Text] [Related]
3. Mechanical suppression of osteolytic bone metastases in advanced breast cancer patients: a randomised controlled study protocol evaluating safety, feasibility and preliminary efficacy of exercise as a targeted medicine.
Hart NH; Galvão DA; Saunders C; Taaffe DR; Feeney KT; Spry NA; Tsoi D; Martin H; Chee R; Clay T; Redfern AD; Newton RU
Trials; 2018 Dec; 19(1):695. PubMed ID: 30572928
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer osteomimicry and its role in bone specific metastasis; an integrative, systematic review of preclinical evidence.
Awolaran O; Brooks SA; Lavender V
Breast; 2016 Dec; 30():156-171. PubMed ID: 27750106
[TBL] [Abstract][Full Text] [Related]
5. [Pathophysiology of bone metastases and new molecular targets involved in bone remodelling].
Clézardin P
Bull Cancer; 2013 Nov; 100(11):1083-91. PubMed ID: 24152978
[TBL] [Abstract][Full Text] [Related]
6. ABL kinases promote breast cancer osteolytic metastasis by modulating tumor-bone interactions through TAZ and STAT5 signaling.
Wang J; Rouse C; Jasper JS; Pendergast AM
Sci Signal; 2016 Feb; 9(413):ra12. PubMed ID: 26838548
[TBL] [Abstract][Full Text] [Related]
7. Osteolytic metastasis in breast cancer: effective prevention strategies.
Mandal CC
Expert Rev Anticancer Ther; 2020 Sep; 20(9):797-811. PubMed ID: 32772585
[TBL] [Abstract][Full Text] [Related]
8. Cancer-secreted hsa-miR-940 induces an osteoblastic phenotype in the bone metastatic microenvironment via targeting ARHGAP1 and FAM134A.
Hashimoto K; Ochi H; Sunamura S; Kosaka N; Mabuchi Y; Fukuda T; Yao K; Kanda H; Ae K; Okawa A; Akazawa C; Ochiya T; Futakuchi M; Takeda S; Sato S
Proc Natl Acad Sci U S A; 2018 Feb; 115(9):2204-2209. PubMed ID: 29440427
[TBL] [Abstract][Full Text] [Related]
9. Increased Dickkopf-1 expression in breast cancer bone metastases.
Voorzanger-Rousselot N; Goehrig D; Journe F; Doriath V; Body JJ; Clézardin P; Garnero P
Br J Cancer; 2007 Oct; 97(7):964-70. PubMed ID: 17876334
[TBL] [Abstract][Full Text] [Related]
10. Bisphosphonate risedronate reduces metastatic human breast cancer burden in bone in nude mice.
Sasaki A; Boyce BF; Story B; Wright KR; Chapman M; Boyce R; Mundy GR; Yoneda T
Cancer Res; 1995 Aug; 55(16):3551-7. PubMed ID: 7627963
[TBL] [Abstract][Full Text] [Related]
11. [Bone metastasis from prostate cancer].
Uemura M; Nonomura N
Clin Calcium; 2014 Aug; 24(8):1169-75. PubMed ID: 25065868
[TBL] [Abstract][Full Text] [Related]
12. Tumour progression and angiogenesis in bone metastasis from breast cancer: new approaches to an old problem.
Pluijm G; Löwik C; Papapoulos S
Cancer Treat Rev; 2000 Feb; 26(1):11-27. PubMed ID: 10660489
[TBL] [Abstract][Full Text] [Related]
13. E-cadherin expression in human breast cancer cells suppresses the development of osteolytic bone metastases in an experimental metastasis model.
Mbalaviele G; Dunstan CR; Sasaki A; Williams PJ; Mundy GR; Yoneda T
Cancer Res; 1996 Sep; 56(17):4063-70. PubMed ID: 8752180
[TBL] [Abstract][Full Text] [Related]
14. The molecular signature of breast cancer metastasis to bone.
Bahrami T; Mokmeli S; Hossieni H; Pourpaknia R; Makani Z; Salmaninejad A; Estiar MA; Hossieni A; Farshbaf A
Anticancer Drugs; 2016 Oct; 27(9):824-31. PubMed ID: 27384592
[TBL] [Abstract][Full Text] [Related]
15. Pathological Crosstalk between Metastatic Breast Cancer Cells and the Bone Microenvironment.
Zarrer J; Haider MT; Smit DJ; Taipaleenmäki H
Biomolecules; 2020 Feb; 10(2):. PubMed ID: 32092997
[TBL] [Abstract][Full Text] [Related]
16. The Breast Cancer to Bone (B2B) Metastases Research Program: a multi-disciplinary investigation of bone metastases from breast cancer.
Brockton NT; Gill SJ; Laborge SL; Paterson AH; Cook LS; Vogel HJ; Shemanko CS; Hanley DA; Magliocco AM; Friedenreich CM
BMC Cancer; 2015 Jul; 15():512. PubMed ID: 26156521
[TBL] [Abstract][Full Text] [Related]
17. What Is Breast in the Bone?
Shemanko CS; Cong Y; Forsyth A
Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27782069
[TBL] [Abstract][Full Text] [Related]
18. The critical role of the ZNF217 oncogene in promoting breast cancer metastasis to the bone.
Bellanger A; Donini CF; Vendrell JA; Lavaud J; Machuca-Gayet I; Ruel M; Vollaire J; Grisard E; Győrffy B; Bièche I; Peyruchaud O; Coll JL; Treilleux I; Maguer-Satta V; Josserand V; Cohen PA
J Pathol; 2017 May; 242(1):73-89. PubMed ID: 28207159
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer metastasis to bone: mechanisms of osteolysis and implications for therapy.
Kozlow W; Guise TA
J Mammary Gland Biol Neoplasia; 2005 Apr; 10(2):169-80. PubMed ID: 16025223
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of osteolytic bone metastases in breast carcinoma.
Käkönen SM; Mundy GR
Cancer; 2003 Feb; 97(3 Suppl):834-9. PubMed ID: 12548583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
